Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
Holding SNDX?
Track your performance easily

Syndax Pharmaceuticals (SNDX) Financial Statements

597 Followers

Syndax Pharmaceuticals Financial Overview

Syndax Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.379; its P/E ratio is -5.55; Syndax Pharmaceuticals is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-1.07. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 3.50M----
Gross Profit$ 3.50M----
EBIT$ -68.02M$ -72.34M$ -72.41M$ -51.08M$ -44.58M
EBITDA$ -64.19M$ -72.34M$ -72.41M$ -54.73M$ -48.30M
Net Income Common Stockholders$ -68.06M$ -72.40M$ -72.47M$ -51.15M$ -44.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 425.10M$ 434.58M$ 570.70M$ 363.56M$ 398.80M
Total Assets$ 476.95M$ 543.03M$ 612.88M$ 399.22M$ 431.34M
Total Debt$ 1.11M$ 1.37M$ 1.61M$ 1.85M$ 2.07M
Net Debt$ -423.98M$ -433.21M$ -569.09M$ -361.71M$ -396.73M
Total Liabilities$ 42.61M$ 51.14M$ 58.68M$ 40.04M$ 31.30M
Stockholders Equity$ 434.34M$ 491.89M$ 554.20M$ 359.19M$ 400.04M
Cash Flow-
Free Cash Flow$ -71.64M$ -83.55M$ -41.35M$ -44.65M$ -35.37M
Operating Cash Flow$ -71.64M$ -83.55M$ -41.35M$ -44.65M$ -35.37M
Investing Cash Flow$ 61.75M$ -99.40M$ -16.29M$ 40.08M$ 73.91M
Financing Cash Flow$ 676.00K$ 2.17M$ 258.48M$ 1.85M$ 1.32M
Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History

Syndax Pharmaceuticals Debt to Assets

Syndax Pharmaceuticals Cash Flow

Syndax Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis